Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

• Status: Terminated
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effect of preventing hyperglycaemia in patients admitted to hospital with acute exacerbations of chronic pulmonary disease.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Royal Bournemouth Hospital
• Collaborator: Sanofi
• Treatments: Insulin; Insulin glulisine; Insulin, Globin Zinc

Criteria

Inclusion criteria

• Patients who are NOT diabetic, admitted with COPD who are likely to be prescribed corticosteroids as part of usual care with an admission glucose level (before steroids) between 6.1 and 11.1 mmol/l.

Exclusion criteria:

• Patients with diabetes mellitus

• Patients who are nil by mouth.

• Patients with severe co-morbid disease with an anticipated life expectancy of < 6 months.

• Patients who are unable to provide informed consent.

• Age <18 years.